Cargando…
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype
INTRODUCTION: Despite improvements in adjuvant therapy, late systemic recurrences remain a lethal consequence of both early- and late-stage breast cancer. A delayed recurrence is thought to arise from a state of tumor dormancy, but the mechanisms that govern tumor dormancy remain poorly understood....
Autores principales: | Cheng, Qing, Chang, Jeffrey T, Gwin, William R, Zhu, Jun, Ambs, Stefan, Geradts, Joseph, Lyerly, H Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187325/ https://www.ncbi.nlm.nih.gov/pubmed/25060555 http://dx.doi.org/10.1186/s13058-014-0407-9 |
Ejemplares similares
-
Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum
por: Chakraborty, Priyanka, et al.
Publicado: (2021) -
Stromal fibroblasts induce metastatic tumor cell clusters via epithelial–mesenchymal plasticity
por: Matsumura, Yuko, et al.
Publicado: (2019) -
Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells
por: Yang, Min, et al.
Publicado: (2016) -
An epithelial-mesenchymal plasticity signature identifies two novel LncRNAs with the opposite regulation
por: Kumar, Pranjal, et al.
Publicado: (2022) -
Metabolic signatures of human breast cancer
por: Mishra, Prachi, et al.
Publicado: (2015)